← Back to Vaccine Database

COVAX-19® Recombinant spike protein + adjuvant

Protein based vaccine · VDDBV0175

Target & Classification

SARS-CoV-2SARS-CoV-2
Protein based vaccine
COVID-19
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials7

NCT IDPhaseDisease / Condition
NCT04453852 Phase 1COVID-19
NCT04428073 Phase 1COVID-19
NCT04944368 Phase 2COVID-19
NCT05005559 Phase 3COVID-19
NCT05148871 Phase 3COVID-19
NCT05279456 Phase 3COVID-19
NCT05175625 Phase 3COVID-19